Video

BioTissue continues the rollout of its corporate rebranding

Author(s):

Kassi Jackson
Conferences|ASCRS

Earlier this year, BioTissue announced the corporate rebrand of its new customer facing entity, including carrying the name over to its surgical business formally known as Amniox Medical. Randy Mansfield, VP of marketing for BioTissue, shares an update at ASCRS 2022.

Related Videos
Bonnie An Henderson, MD, and EnVision Summit 2025 preview
Vikas Chopra, MD, at AAO 2024: The role of MIGS in earlier intervention and safer techniques
Related Content
Binocular amblyopia home treatment: The next step after patching
November 19th 2024

Binocular amblyopia home treatment: The next step after patching

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

AI-related innovations for laser cataract technology mark a milestone in history of device
October 30th 2024

AI-related innovations for laser cataract technology mark a milestone in history of device

Robert Chang, MD, discusses the impact of large language models on glaucoma care and AI in ophthalmology
November 5th 2024

Innovation Series: Putting the buzz of large language models in ophthalmology into perspective with Robert T. Chang, MD

The top 10 takeaways from AAO 2024
October 23rd 2024

The top 10 takeaways from AAO 2024

Life Biosciences reports advances in nonhuman primate studies on partial epigenetic reprogramming for restoring visual function
October 22nd 2024

Life Biosciences reports advances in nonhuman primate studies on partial epigenetic reprogramming for restoring visual function

© 2024 MJH Life Sciences

All rights reserved.